After chemotherapy, SUMO1P3 levels decreased significantly in chemo-sensitive patients, but remained unchanged in chemo-resistant patients, highlighting SUMO1P3 as a potential prognostic EV biomarker for BC. The gene discussed is SUMO1P3; the disease is breast cancer.